Cite
HARVARD Citation
Milojkovic, D. et al. (2021). Real‐world tyrosine kinase inhibitor treatment pathways, monitoring patterns and responses in patients with chronic myeloid leukaemia in the United Kingdom: the UK TARGET CML study. British journal of haematology. pp. 62-74. [Online].